Thursday, September 10, 2026
Heart Failure Therapy in Transition: From Guideline to Precision Medicine
What’s New in 2026? A Deep Dive into the ESC HF Guidelines
Friday, September 11, 2026
[Joint Session with HFA-ESC]
Shaping the Future of Personalized Heart Failure Care
Friday, September 11, 2026
[Joint Session with HFA-ESC]
Shaping the Future of Personalized Heart Failure Care
Towards Personalized Device Therapy in Heart Failure: Rethinking CRT-D
Friday, September 11, 2026
Presidential Lecture
Heart Failure 2026: From Guidelines to Precision, Prevention and Advocacy
Saturday, September 12, 2026
Meet the Expert 2
Saturday, September 12, 2026
CKM Syndrome: New Insights, Emerging Therapies, and Unresolved Challenges
Congestion and Cardiorenal Interaction in Heart Failure
Friday, September 11, 2026
[Joint Session with HFA-ESC]
Shaping the Future of Personalized Heart Failure Care
Towards Personalized GDMT in Heart Failure: Rethinking Phenotype-Based Therapy
Saturday, September 12, 2026
Meet the Expert 2
Saturday, September 12, 2026
CKM Syndrome: New Insights, Emerging Therapies, and Unresolved Challenges
Saturday, September 12, 2026
Tailoring Modern HF Therapy: Integrating Evidence-Based Evolution into Practice
Big Data to Bedside: Harmonizing Registry Evidence with Randomized Clinical Trials
Friday, September 11, 2026
[Joint Session with HFA-ESC]
Shaping the Future of Personalized Heart Failure Care
Discussion
Saturday, September 12, 2026
Tailoring Modern HF Therapy: Integrating Evidence-Based Evolution into Practice
Discussion
Thursday, September 10, 2026
[Joint Session with HFSA]
Emerging Evidence and Changing Treatment Paradigms in Cardiomyopathy
Thursday, September 10, 2026
[Joint Session with HFSA]
Emerging Evidence and Changing Treatment Paradigms in Cardiomyopathy
Management of Non-obstructive HCM: Who Benefits from Cardiac Myosin Inhibitor?
Friday, September 11, 2026
Mechanisms of Heart Failure: From Basic Science to Clinical Insight
Friday, September 11, 2026
Mechanisms of Heart Failure: From Basic Science to Clinical Insight
[Presidential Lecture From HFSA] Molecular Mechanisms of Heart Failure: From Bench to Bedside
Saturday, September 12, 2026
Meet the Expert 2
Thursday, September 10, 2026
Luncheon Session 1
State of the Art Diagnostics and Treatment of ATTR Cardiac Amyloidosis in 2026
Thursday, September 10, 2026
[Joint Session with HFSA]
Emerging Evidence and Changing Treatment Paradigms in Cardiomyopathy
ATTR-CM in the United States: Evidence to Practice
Friday, September 11, 2026
Cardiac Amyloidosis 2026: Expanding Therapeutic Frontiers and Unresolved Controversies
The Importance of Timing: Early Tafamidis Therapy for Sustained Disease Modification
Saturday, September 12, 2026
Meets the Industries 3
Real-World Experience with Tafamidis in Clinical Practice
Thursday, September 10, 2026
Integrating Finerenone Across the CKM Continuum
Luncheon Session 2
Friday, September 11, 2026
Advancing Chronic HF Management: From Evidence to Early Clinical Integration
Luncheon Session 5
Jardiance in Chronic HF: Early Initiation and Practical Integration Across EF
Saturday, September 12, 2026
Meet the Expert 2
Saturday, September 12, 2026
CKM Syndrome: New Insights, Emerging Therapies, and Unresolved Challenges
Who Should Receive MRAs in CKM Syndrome? Bridging the Gap Between Guidelines and Practice
Saturday, September 12, 2026
Tailoring Modern HF Therapy: Integrating Evidence-Based Evolution into Practice
SGLT2 Inhibitors in Heart Failure: Translating Evidence into Multi-Organ Benefits
Thursday, September 10, 2026
Current Landscape and Future Pathways of Transcatheter Heart Failure Management
Interatrial Shunting in HF: Contemporary Evidence and Ongoing Challenges
Friday, September 11, 2026
Meet the Expert 1
Friday, September 11, 2026
ARNI Beyond Conventional Boundaries: Expanding Across the CV Continuum
Meets the Industries 1
Global Perspectives on the Role of ARNI Across the HF Spectrum
Friday, September 11, 2026
Beyond Human Touch: Remote Monitoring & Protocolized Care Pathways in Heart Failure Clinics
Friday, September 11, 2026
Beyond Human Touch: Remote Monitoring & Protocolized Care Pathways in Heart Failure Clinics
Remote Monitoring That Changes Outcomes: What to Measure, When to Act
Saturday, September 12, 2026
Changing the Trajectory Before the Next Event with ARNI
Luncheon Session 8
A U.S. Perspective: Acting Earlier to Prevent the Next Heart Failure Event with ARNI
Thursday, September 10, 2026
[Joint Session with HFSA]
Emerging Evidence and Changing Treatment Paradigms in Cardiomyopathy
Discussion
Friday, September 11, 2026
Meet the Expert 1
Saturday, September 12, 2026
Hypertrophic Cardiomyopathy in 2026: From Risk Stratification to Targeted Therapy
Saturday, September 12, 2026
Hypertrophic Cardiomyopathy in 2026: From Risk Stratification to Targeted Therapy
The New Era of HCM: Myosin Inhibitors and Personalized Treatment Strategies
Thursday, September 10, 2026
Integrating Finerenone Across the CKM Continuum
Luncheon Session 2
The Unique Value of Kerendia®: From Mechanism to Kidney & HF Prevention
Thursday, September 10, 2026
Current Landscape and Future Pathways of Transcatheter Heart Failure Management
Discussion
Friday, September 11, 2026
A New Era in HFpEF/HFmrEF: The Role of Finerenone in Double Prevention
[Morning Session 1]
Prevention-2: Beyond First Events-Reducing Total HF Burden in HFpEF/HFmrEF with Finerenone
Thursday, September 10, 2026
Current Landscape and Future Pathways of Transcatheter Heart Failure Management
Friday, September 11, 2026
Meet the Expert 1
Friday, September 11, 2026
Presidential Lecture
Heart Failure in Japan: The Role of the Japanese Heart Failure Society
Saturday, September 12, 2026
[Joint Session with JHFS]
Decision-Making in Heart Failure: Navigating Uncertainty and Unmet Needs
Saturday, September 12, 2026
Tailoring Modern HF Therapy: Integrating Evidence-Based Evolution into Practice
Saturday, September 12, 2026
[Joint Session with JHFS]
Decision-Making in Heart Failure: Navigating Uncertainty and Unmet Needs
BNP-Based Heart Failure Care: A Japanese Model for Precision Medicine
Saturday, September 12, 2026
Hot Topics in HF: Navigating the EF Spectrum
Top 3 Clinical Research in HFpEF (2025-2026)
Saturday, September 12, 2026
[Joint Session with JHFS]
Decision-Making in Heart Failure: Navigating Uncertainty and Unmet Needs
Atrial Functional MR in Heart Failure: From Evidence to Practice
Thursday, September 10, 2026
Heart Failure Therapy in Transition: From Guideline to Precision Medicine
Revisiting the Effects of Novel HF Therapies Through Genomic and Multi-Omics Analyses
Friday, September 11, 2026
Meet the Expert 1
Saturday, September 12, 2026
CKM Syndrome: New Insights, Emerging Therapies, and Unresolved Challenges
Redefining Obesity Treatment in Heart Failure Prevention: Targeting Metabolically Unhealthy Obesity
Thursday, September 10, 2026
Heart Failure Therapy in Transition: From Guideline to Precision Medicine
How Guidelines Shape HF Care? Unique Insights from Japan
Thursday, September 10, 2026
Current Landscape and Future Pathways of Transcatheter Heart Failure Management
T-TEER in Functional TR Management: Patient Selection and Outcomes
Fuwai Hospital, China
Thursday, September 10, 2026
[Joint Session with CHFA]
Global Lessons of Asian Heart Failure
Saturday, September 12, 2026
Changing the Trajectory Before the Next Event with ARNI
Luncheon Session 8
Fuwai Hospital, China
Thursday, September 10, 2026
Current Landscape and Future Pathways of Transcatheter Heart Failure Management
Discussion
Thursday, September 10, 2026
[Joint Session with CHFA]
Global Lessons of Asian Heart Failure
Quadruple Therapy in Asian Patients: Efficacy, Tolerability, and Dosing Issues
Friday, September 11, 2026
Beyond Human Touch: Remote Monitoring & Protocolized Care Pathways in Heart Failure Clinics
Discussion
Saturday, September 12, 2026
Hot Topics in HF: Navigating the EF Spectrum
Thursday, September 10, 2026
[Joint Session with CHFA]
Global Lessons of Asian Heart Failure
Mechanical Circulatory Support in Asian Patients with Heart Failure
Friday, September 11, 2026
Beyond Survival: Managing Heart Failure in the Era of Modern Cancer Therapy
Permissive Cardiotoxicity and Intensive Monitoring: A New Paradigm in Cardio-oncology
Saturday, September 12, 2026
Hot Topics in HF: Navigating the EF Spectrum
Top 3 Clinical Research in HFrEF (2025-2026)
